| Reckitt Benckiser (Switzerland) AG - Gavisconell Liquid Mint, Suspension zum Einnehmen in Flaschen | | 66997 | | 01 | | Gavisconell Liquid Mint | | Suspension zum Einnehmen in Flaschen | | A02AX | | Antacida, andere Kombinationen | | 01.11.2018 | | |
| | Composition | | natrii alginas 500 mg, natrii hydrogenocarbonas 267 mg, calcii carbonas 160 mg, carbomerum 974P, natrii hydroxidum ad pH, aqua purificata, menthae piperitae aetheroleum, saccharinum natricum, propylis parahydroxybenzoas 6 mg, E 218 40 mg, ad suspensionem pro 10 ml corresp. natrium 142.6 mg. | | Packungsbestandteile | | Suspension zum Einnehmen in Flaschen | | | | | | | | Principe actif | Concentr. |
|---|
| Calcium Carbonate | 160 mg | | Sodium Alginate | 500 mg | | Sodium Hydrogenocarbonate | 267 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Calcium Carbonate | 160 mg | | Sodium Alginate | 500 mg | | Sodium Hydrogenocarbonate | 267 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| Aromatica | | | | E 218 | | conserv. | | Propylis Parahydroxybenzoas | | conserv. | | Saccharinum Natricum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 150 ml | DDP | DDP | D | | Oui | | 002 | 300 ml | 5.83 | 10.75 | D | LS | Oui |
|
|
